Results 171 to 180 of about 346,538 (383)

FEATURES OF THE BILIARY TRACT DYSFUNCTIONAL DISORDERS DURING NON-REMOVABLE EQUIPMENT TREATMENT IN CHILDREN WITH DENTOALVEOLAR ANOMALIES

Мать и дитя в Кузбассе, 2017
Children biliary dysfunction occupied a leading place in the structure of gastroenterological diseases. During the long orthodontic treatment the dental anomalies supported dysfunction of biliary system and contributed to its progression.
Тамара Анатольевна Сиротченко, Юрий Анатольевич Калиниченко, Анна Александровна Бобрышева   +2 more
doaj  

Family doctor’s tactics for biliary tract diseases (diagnostic criteria) [PDF]

, 2019
К.В. Вовк, O.V. Sokruto, O. G. Reznichenko, S.V. Gridneva, M. V. Martynenko   +4 more
openalex   +1 more source

Constant painful point in diseases of the liver and biliary tract. Sabatini (after ref. F. Chir., 1926, no. 1)

, 2021
M. Friedland
openalex   +2 more sources

Microbiome‐Informed Dosing: Exploring Gut Microbial Communities Impact on Mycophenolate Enterohepatic Circulation and Therapeutic Target Achievement

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacomicrobiomics is an emerging field due to important microbiome effects on pharmacokinetics and clinical outcomes. However, the application of this knowledge remains limited. Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant, mycophenolate mofetil (MMF).
Abdelrahman Saqr, Shen Cheng, Mahmoud Al‐Kofahi, Christopher Staley, Pamala A. Jacobson   +4 more
wiley   +1 more source

Nicodine electrophoresis for diseases of the gallbladder and biliary tract

, 1982
M. K. Gizzatullina
openalex   +2 more sources

Preoperative controlling nutritional status score predicts systemic disease recurrence in patients with resectable biliary tract cancer

, 2022
Masato Mito, Jun Sakata, Yuki Hirose, Shun Abe, Seiji Saito, Yohei Miura, Hirosuke Ishikawa, Kohei Miura, Kazuyasu Takizawa, Hiroshi Ichikawa, Yoshifumi Shimada, Takashi Kobayashi, Toshifumi Wakai   +12 more
openalex   +1 more source

Pharmacomicrobiomics

Clinical Pharmacology &Therapeutics, EarlyView.
Oral medications encounter gut commensal microbes that participate directly and indirectly in drug effects through metabolism, interactions with drug metabolites, or production of substrates that compete with drugs for drug‐metabolizing enzymes, consequently influencing drug pharmacokinetics.
Naomi Gronich, Naama Geva‐Zatorsky, Rachel Herren, Libusha Kelly, Ziv Cohen, Haiying Zhou, Yi‐Ching Chen, Khalid Shah, Talin A. Robinson‐Catala, Grecia Frisby, Jason H. Karnes, Lisl Shoda   +11 more
wiley   +1 more source

Express diagnostics of acute liver and biliary tract diseases with jaundice syndrome in emergency surgery

, 1983
I. A. Salikhov, В. Н. Воронин, N. N. Zolkin   +2 more
openalex   +2 more sources

Infections after liver transplantation: An analysis of 101 consecutive cases [PDF]

, 1988
Esquivel, C, Ho, M, Iwatsuki, S, Kusne, S, Makowka, L, Singh, N, Starzl, TE, Stephen Dummer, J, Tzakis, AG   +8 more
core   +1 more source

Evolving Real‐World Data and Evidence Use for New Drugs and Regenerative Medical Products Approvals in Japan—An Analysis of the 6‐Year Trend

Clinical Pharmacology &Therapeutics, EarlyView.
Several regulatory initiatives have been made to clarify the acceptability and requirements of real‐world data and real‐world evidence (RWD/E) for the benefit/risk assessment of new medical products in Japan. The objectives of this review were to characterize the use of RWD/E in regulatory applications of new medical products and to describe the ...
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source